challenges associated with gene therapies for scd and thalassemia
Published 5 months ago • 54 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:11
gene therapy for scd: unanswered questions
-
2:20
improving the accessibility of gene therapy: developing in vivo techniques
-
1:41
developing novel gene therapy approaches for hemoglobinopathies
-
1:14
the challenges associated with treating patients with non-transfusion-dependent thalassemia
-
1:27
the challenges of implementing gene therapies for hemophilia in clinical practice
-
1:35
challenges with diagnosing mds and future outlooks
-
1:58
gene therapy is the future of sickle cell disease
-
2:32
gene therapies in sickle cell
-
0:46
is there potential for the use of combination therapies in sickle cell disease?
-
0:42
the limited access to novel therapeutics for sickle cell disease in lmics
-
0:48
an overview of challenges that remain in the treatment of patients with al amyloidosis
-
1:48
toxicity of beti-cel in transfusion-dependent β-thalassemia
-
7:02
bcl11a as therapeutic target in scd: gene therapy trial
-
1:36
the limitations and future of precision medicine in sickle cell disease
-
7:30
genetic targeting in sickle cell disease
-
1:59
prospective study evaluating complement activation in patients with sickle cell disease
-
2:05
emerging therapeutic challenges to treating patients with multiple myeloma
-
5:48
thalassemia: alpha & beta-thalassemias, genetics, pathophysiology, diagnosis & treatment, animation
-
1:43
the role of complement activation in complications of sickle cell disease